Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2221 to 2235 of 8231 results

  1. Atrasentan for treating primary IgA nephropathy [ID6558]

    Awaiting development Reference number: GID-TA11756 Expected publication date: TBC

  2. Fidrisertib for reducing heterotopic ossification caused by fibrodysplasia ossificans progressiva in people 5 years and over [TSID12216]

    Awaiting development Reference number: GID-TA11805 Expected publication date: TBC

  3. Tildrakizumab for treating active psoriatic arthritis [TSID12218]

    Awaiting development Reference number: GID-TA11807 Expected publication date: TBC

  4. Secukinumab for treating relapsed polymyalgia rheumatica [ID6599]

    Awaiting development Reference number: GID-TA11806 Expected publication date: TBC

  5. Venetoclax with azacitidine for treating acute myeloid leukaemia before and after an allogeneic stem cell transplant [ID6468]

    Awaiting development Reference number: GID-TA11581 Expected publication date: TBC

  6. Tiragolumab–atezolizumab for PD-L1-positive recurrent or advanced non-small-cell lung cancer untreated with checkpoint inhibitors [TSID12064]

    Awaiting development Reference number: GID-TA11594 Expected publication date: TBC

  7. Chemical Component Separation

    Topic prioritisation

  8. Extracorporeal bioartificial liver assist therapy

    Topic prioritisation

  9. Inserting a bupivicaine-collagen implant into a surgical wound for postoperative analgesia

    Topic prioritisation

  10. An aortic cuff counterpulsation system for the treatment of heart failure

    Topic prioritisation

  11. Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer

    Topic prioritisation

  12. Transnasal Panendoscopy

    Topic prioritisation

  13. Helium plasma coagulation for treating Respiratory Papillomatosis

    Topic prioritisation

  14. Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) system for pancreatic cystic neoplasms and neuroendocrine tumours

    Topic prioritisation

  15. High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia

    Topic prioritisation